Multi4 Medical Clinical Study on Bladder Cancer Treatment Published in BJUI
Multi4 Medical's first-in-human study confirms bladder cancer treatment can shift from the operating room to an outpatient clinic. The new method enables complete treatment and diagnostic sampling in minutes on awake patients.
Multi4 Medical has published the findings of its first-in-human clinical study in the British Journal of Urology International (BJUI). The study examines a treatment for bladder cancer that allows the procedure to move from traditional operating rooms to outpatient clinics.
The new method enables patients to receive complete treatment and diagnostic samples within minutes. The procedure can be performed on awake patients, significantly reducing hospital strain and improving the patient experience. Multi4 Medical has also initiated the first patient treatments in Europe using this new technique.
Publication in BJUI confirms the method's potential to reshape bladder cancer treatment practices, aiming for more accessible and less invasive care. The company has received significant market authorization for the method in certain regions.
Multi4 Medical's approach may offer new options for bladder cancer patients seeking less burdensome treatment alternatives. The company is proceeding with broader implementation of the method across Europe.